← SynDRA
RANIRESTAT
SynDRA canonical compound SYN0004626 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | AKR1B1 |
| Mechanism of action | aldose reductase inhibitor |
All known targets
Mechanisms of action (all sources)
- aldose reductase inhibitor
- AKR1B1 INHIBITOR
Drug classes
Cross-references
Synonyms
- AS-3201
- AS 3201
- Z26P56GFTV
- SX-3030
- SX-3201
- SX-3202
- ranirestatum
- RefChem:875121
- DTXCID0086133
- Ranirestat [INN]
- C17H11BrFN3O4
- UNII-Z26P56GFTV
- Ranirestat (JAN/INN)
- RANIRESTAT [JAN]
- RANIRESTAT [WHO-DD]
- SCHEMBL498993
- orb1706732
- Ranirestat, >=97% (HPLC)
- SCHEMBL29672907
- CHEBI:233577
- BDBM50067407
- MFCD00920915
- AKOS030526562
- SB17385
- NCGC00484081-01
- DA-57348
- HY-15314
- MS-27366
- NS00068346
- D06403
- F85182
- T16723
- BRD-K50489389-001-01-8
- رانیرستات
Look up RANIRESTAT in the interactive SynDRA portal →